Someplace in here a smart person could figure out what further research is needed to make something useful out of this. But since we don't have anyone in our stroke associations with two functioning neurons the answers will not be coming from there.
The Role of Monocytes in Ischemic Stroke Pathobiology: New Avenues to Explore
- 1Neuroscience Axis, CHU de Québec Research Center (CHUL), Québec City, QC, Canada
- 2Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University, Québec City, QC, Canada
Introduction
Stroke is the third leading cause of death and the first
cause of disability in industrialized world. Ischemic stroke accounts
for the majority of stroke cases, whereas the remaining stroke cases are
hemorrhagic (Dirnagl et al., 1999).
Regional blood supply disruption initiates the ischemic cascade that
leads to neuronal death and rapid loss of neuronal function (Dirnagl et al., 1999).
The ischemic cascade is characterized by the activation of several
signaling pathways that compromise cell survival and function (Mehta et al., 2007).
Ischemic stroke triggers blood-brain barrier (BBB) breakdown, thus
contributing to the secondary progression of ischemic injury by
increasing brain edema and exacerbating the inflammatory response in the
sub-acute phase (hours to days after ischemic stroke onset; Dirnagl et al., 1999; Fagan et al., 2004).
The severity of these early events reduces the capacity of neurons to
recover in the chronic phase (days to weeks after ischemic stroke
onset), thus significantly worsening stroke outcomes (Moskowitz et al., 2010).
Inflammation plays a central role in ischemic stroke pathobiology (Jin et al., 2010).
Following ischemic stroke, microglia, which are brain resident
macrophages, are activated and circulating immune cells, such as
monocytes, neutrophils and lymphocytes are recruited to injury site (Jin et al., 2010). Among these immune cells, monocytes that give rise to macrophages play a particularly important role (Chiba and Umegaki, 2013).
Initially, the presence of monocytes at the injury site has been
suggested to contribute to ischemic injury exacerbation in the acute
phase (minutes to hours after ischemic stroke onset; Chen et al., 2003).
However, the experimental approaches that aimed at depleting these
cells in ischemic stroke animal models worsened ischemic injury by
destabilizing brain microvasculature (Gliem et al., 2012).
These reports outline the complex and multifaceted role of monocytes in
ischemic stroke pathobiology. As such, this mini-review aims to
summarize and discuss the recent findings that addressed the role of
different monocyte subsets in ischemic stroke pathobiology, which may
have direct implication on stroke therapies.
No comments:
Post a Comment